Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Newmark Recaps 300 Third Street in Cambridge; Fourth for Seller Totals $3.2B
Newmark has completed the recapitalization of 300 Third Street, a six-story 131,963-square-foot Class A laboratory/office asset in Cambridge, MA. The transaction is the seller’s fourth recapitalization since 2019 overseen by Newmark for its assets along Kendall Square’s Binney Street corridor, with a total consideration of $3.2 billion.
Robert Griffin, Edward Maher, Matthew Pullen and Samantha Hallowell of Newmark represented the seller. William Sleeper of Newmark provided financial analysis support.
300 Third Street’s 129,424-square-foot laboratory/office component is fully leased to Alnylam, a pharmaceutical company that is recognized for developing the world’s first and only RNAi therapeutics. Its 2,539-square-foot retail component is fully leased to Fuji at Kendall, an upscale sushi restaurant. The property also features a 139-space parking garage.
300 Third Street is situated within a five-minute walk of the MBTA Red Line’s Kendall/MIT subway station, which facilitates access across the rest of Cambridge and Downtown Boston.
- ◦Financing
